Gadopiclenol for Cardiac MRI: Comparison of Myocardial T1 Relaxation Times and Subjective Image Quality at Different Doses in Patients With Anderson-Fabry Disease.
OBJECTIVES Due to its high relaxivity, the second-generation gadolinium-based contrast agent gadopiclenol has been shown to provide equally high image quality with reduced gadolinium dose. Gadopiclenol has not yet been approved for cardiac magnetic resonance imaging (CMR). The aim of this observational feasibility stud...